White Matter Alteration of the Cingulum in Parkinson Disease with and without Dementia: Evaluation by Diffusion Tensor Tract–Specific Analysis

References

1. 1.↵
   1. de Lau LM,
   2. Breteler MM

   . Epidemiology of Parkinson's disease. Lancet Neurol 2006;5:525–35

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Obeso JA,
   2. Rodriguez-Oroz MC,
   3. Rodriguez M,
   4. et al

   . Pathophysiology of the basal ganglia in Parkinson's disease. Trends Neurosci 2000;23:S8–19

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Braak H,
   2. Del Tredici K

   . Invited article: nervous system pathology in sporadic Parkinson disease. Neurology 2008;70:1916–25

   FREE Full Text
4. 4.↵
   1. Braak H,
   2. Del Tredici K,
   3. Bratzke H,
   4. et al

   . Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages). J Neurol 2002;249(suppl 3):III/1–5
5. 5.↵
   1. Braak H,
   2. Del Tredici K,
   3. Rub U,
   4. et al

   . Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197–211

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Braak H,
   2. Ghebremedhin E,
   3. Rub U,
   4. et al

   . Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 2004;318:121–34

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Aarsland D,
   2. Tandberg E,
   3. Larsen JP,
   4. et al

   . Frequency of dementia in Parkinson disease. Arch Neurol 1996;53:538–42

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Marder K,
   2. Tang MX,
   3. Cote L,
   4. et al

   . The frequency and associated risk factors for dementia in patients with Parkinson's disease. Arch Neurol 1995;52:695–701

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Vaillancourt DE,
   2. Spraker MB,
   3. Prodoehl J,
   4. et al

   . High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology 2009;72:1378–84

   Abstract/FREE Full Text
10. 10.↵
    1. Gattellaro G,
    2. Minati L,
    3. Grisoli M,
    4. et al

    . White matter involvement in idiopathic Parkinson disease: a diffusion tensor imaging study. AJNR Am J Neuroradiol 2009;30:1222–26

    Abstract/FREE Full Text
11. 11.↵
    1. Karagulle Kendi AT,
    2. Lehericy S,
    3. Luciana M,
    4. et al

    . Altered diffusion in the frontal lobe in Parkinson disease. AJNR Am J Neuroradiol 2008;29:501–05

    Abstract/FREE Full Text
12. 12.↵
    1. Matsui H,
    2. Nishinaka K,
    3. Oda M,
    4. et al

    . Dementia in Parkinson's disease: diffusion tensor imaging. Acta Neurol Scand 2007;116:177–81

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Kövari E,
    2. Gold G,
    3. Herrmann FR,
    4. et al

    . Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease. Acta Neuropathol 2003;106:83–88

    PubMed
14. 14.↵
    1. Duvernoy HM

    The Human Hippocampus: Functional Anatomy, Vascularization, and Serial Sections with MRI. Berlin, Germany: Springer-Verlag; 2005
15. 15.↵
    1. Vogt BA,
    2. Nimchinsky EA,
    3. Vogt LJ,
    4. et al

    . Human cingulate cortex: surface features, flat maps, and cytoarchitecture. J Comp Neurol 1995;359:490–506

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Aoki S,
    2. Iwata NK,
    3. Masutani Y,
    4. et al

    . Quantitative evaluation of the pyramidal tract segmented by diffusion tensor tractography: feasibility study in patients with amyotrophic lateral sclerosis. Radiat Med 2005;23:195–99

    PubMed
17. 17.↵
    1. Kunimatsu A,
    2. Aoki S,
    3. Masutani Y,
    4. et al

    . Three-dimensional white matter tractography by diffusion tensor imaging in ischaemic stroke involving the corticospinal tract. Neuroradiology 2003;45:532–35

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Hughes AJ,
    2. Daniel SE,
    3. Kilford L,
    4. et al

    . Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181–84

    Abstract/FREE Full Text
19. 19.↵
    1. Folstein MF,
    2. Folstein SE,
    3. McHugh PR

    . “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–98

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Goetz CG,
    2. Emre M,
    3. Dubois B

    . Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis. Ann Neurol 2008;64(suppl 2):S81–92

    CrossRefPubMed
21. 21.↵
    1. Kubicki M,
    2. Westin CF,
    3. Maier SE,
    4. et al

    . Uncinate fasciculus findings in schizophrenia: a magnetic resonance diffusion tensor imaging study. Am J Psychiatry 2002;159:813–20

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Pajevic S,
    2. Pierpaoli C

    . Color schemes to represent the orientation of anisotropic tissues from diffusion tensor data: application to white matter fiber tract mapping in the human brain. Magn Reson Med 2000;43:921
23. 23.↵
    1. Mori S,
    2. Crain BJ,
    3. Chacko VP,
    4. et al

    . Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging. Ann Neurol 1999;45:265–69

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Wakana S,
    2. Jiang H,
    3. Nagae-Poetscher LM,
    4. et al

    . Fiber tract-based atlas of human white matter anatomy. Radiology 2004;230:77–87

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Yasmin H,
    2. Aoki S,
    3. Abe O,
    4. et al

    . Tract-specific analysis of white matter pathways in healthy subjects: a pilot study using diffusion tensor MRI. Neuroradiology 2009;51:831–40

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Abe O,
    2. Aoki S,
    3. Hayashi N,
    4. et al

    . Normal aging in the central nervous system: quantitative MR diffusion-tensor analysis. Neurobiol Aging 2002;23:433–41

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Firbank MJ,
    2. Blamire AM,
    3. Krishnan MS,
    4. et al

    . Atrophy is associated with posterior cingulate white matter disruption in dementia with Lewy bodies and Alzheimer's disease. Neuroimage 2007;36:1–7

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Taoka T,
    2. Kin T,
    3. Nakagawa H,
    4. et al

    . Diffusivity and diffusion anisotropy of cerebellar peduncles in cases of spinocerebellar degenerative disease. Neuroimage 2007;37:387–93

    CrossRefPubMed
29. 29.↵
    1. Nagano-Saito A,
    2. Washimi Y,
    3. Arahata Y,
    4. et al

    . Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology 2005;64:224–29

    Abstract/FREE Full Text
30. 30.↵
    1. Beyer MK,
    2. Janvin CC,
    3. Larsen JP,
    4. et al

    . A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry. J Neurol Neurosurg Psychiatry 2007;78:254–59

    Abstract/FREE Full Text
31. 31.↵
    1. Camicioli RM,
    2. Korzan JR,
    3. Foster SL,
    4. et al

    . Posterior cingulate metabolic changes occur in Parkinson's disease patients without dementia. Neurosci Lett 2004;354:177–80

    CrossRefPubMedWeb of Science
32. 32.↵
    1. Vander Borght T,
    2. Minoshima S,
    3. Giordani B,
    4. et al

    . Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity. J Nucl Med 1997;38:797–802

    Abstract/FREE Full Text
33. 33.↵
    1. Mito Y,
    2. Yoshida K,
    3. Yabe I,
    4. et al

    . Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease. Clin Neurol Neurosurg 2005;107:396–403

    CrossRefPubMedWeb of Science
34. 34.↵
    1. Mito Y,
    2. Yoshida K,
    3. Yabe I,
    4. et al

    . Brain SPECT analysis by 3D-SSP and phenotype of Parkinson's disease. J Neurol Sci 2006;241:67–72

    CrossRefPubMed
35. 35.↵
    1. Abe O,
    2. Yamasue H,
    3. Kasai K,
    4. et al

    . Voxel-based diffusion tensor analysis reveals aberrant anterior cingulum integrity in posttraumatic stress disorder due to terrorism. Psychiatry Res 2006;146:231–42

    CrossRefPubMed
36. 36.↵
    1. Buchsbaum MS,
    2. Tang CY,
    3. Peled S,
    4. et al

    . MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia. Neuroreport 1998;9:425–30

    CrossRefPubMedWeb of Science
37. 37.↵
    1. Docherty MJ,
    2. Burn DJ

    . Parkinson's disease dementia. Curr Neurol Neurosci Rep 2010;10:292–98

    CrossRefPubMed
38. 38.↵
    1. Mahieux F,
    2. Fenelon G,
    3. Flahault A,
    4. et al

    . Neuropsychological prediction of dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry 1998;64:178–83

    Abstract/FREE Full Text
39. 39.↵
    1. Brown RG,
    2. Marsden CD

    . How common is dementia in Parkinson's disease? Lancet 1984;2:1262–65

    CrossRefPubMedWeb of Science
40. 40.↵
    1. Cooper JA,
    2. Sagar HJ,
    3. Jordan N,
    4. et al

    . Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain 1991;114(pt 5):2095–122

    Abstract/FREE Full Text
41. 41.↵
    1. Lees AJ,
    2. Smith E

    . Cognitive deficits in the early stages of Parkinson's disease. Brain 1993;106(pt 2):257–70